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Abstract.  Human carcinoembryonic antigen (CEA), a 
widely used tumor marker, is a member of a family of 
cell surface glycoproteins that are overexpressed in 
many carcinomas. CEA has been shown to function in 
vitro as a homotypic intercellular adhesion molecule. 
This correlation of overproduction of an adhesion mol- 
ecule with neoplastic transformation provoked a test of 
the effect of CEA on cell differentiation. Using stable 
CEA transfectants of the rat L6 myoblast cell line as a 
model system of differentiation, we show that fusion 
into myotubes and, in fact, the entire molecular pro- 
gram of differentiation, including creatine phos- 
phokinase upregulation, myogenin upregulation, and 
~-actin downregulation are completely abrogated by 
the ectopic expression of CEA. The blocking of the 
upregulation of myogenin, a transcriptional regulator 
responsible for the execution of the entire myogenic 
differentiation program, indicates that CEA expression 
intercepts the process at a very early stage.  The adhe- 
sion function of CEA is essential for this effect since 
an adhesion-defective N domain deletion mutant of 
CEA was ineffective  in blocking fusion and CEA 
transfectants treated with adhesion-blocking peptides 
fused normally. Furthermore, CEA transfectants main- 
tain their high division potential, whereas control 
transfectants lose division potential with differentiation 
similarly to the parental cell line. Thus the expression 
of functional CEA on the surface of cells can block 
terminal differentiation and maintain proliferative 
potential. 
H 
uraAN carcinoembryonic antigen (CEA) ~  (Gold and 
Freedman, 1965), is a member of a family of cell 
surface glycoproteins which appear at high levels in 
the blood of  patients bearing a wide variety of  tumors includ- 
ing colon, breast, and lung carcinomas (Zimmermann et al., 
1988; Cournoyer et al.,  1988), a phenomenon that has led 
to its widespread use as a tumor marker in the prognosis and 
management of colon cancer (Shuster et al., 1980; Terry et 
al., 1974). The basis for this marked elevation in blood levels 
of CEA is likely due to an increased accessibility to the vas- 
cular system in tumors,  with some workers finding no in- 
crease in cellular CEA production (Abbasi et al., 1992) and 
others  a  true  increase  due  to  malignant  transformation 
(Higashide  et  al.,  1990); our  evidence  favors the  latter 
(Boucher et al.,  1989). 
CEA is a member of the immunoglobulin supergene fam- 
ily (Williams,  1987; Paxton et al.,  1987) consisting  of a 
processed leader sequence, a V-like amino-terminal domain, 
six C2-set-like repeat domains in homologous pairs denoted 
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A1B1, A2B2,  and A3B3, and a  short  COOH-terminal  se- 
quence  which  is  processed  to leave a  glycophosphatidyl- 
inositol (GPI) bond to the external cell membrane (Fig. 2) 
(Beauchemin et al.,  1987). 
CEA has recently been demonstrated  to act in vitro,  at 
least,  as  a  calcium-independent,  homotypic,  intercellular 
adhesion molecule (Benchimol et al., 1989). The adhesion 
function could be of relevance to the observed correlation 
between CEA family overproduction and cancer. We have 
suggested an instrumental  model (Benchimol et al.,  1989) 
based on the following rationale:  the adult colonic epithe- 
lium consists of a monolayer of polarized cells which divide 
at the base of the crypts and move up the sides, undergoing 
a precise terminal differentiation as they progress to be even- 
tually sloughed offinto  the lumen of  the bowel; CEA produc- 
tion in these  cells tends to be low and apical;  early em- 
bryonic epithelium, on the other hand, is multilayered and 
CEA is found over the entire cell surface (Benchimol et al., 
1989); colonic carcinomas also frequently consist of mul- 
tilayered epithelial cells with CEA expressed over the entire 
cell surface. 
We have suggested that this apparent reversion to an em- 
bryonic  multilayered epithelial architecture  in adult carci- 
nomas could be due to an imbalance in the presentation of 
adhesion molecules  on the surface of colonocytes arising 
from inappropriate production of CEA; this, in turn, could 
lead  to  a  disruption  of differentiation  leaving cells  with 
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tive outgrowth of cells with further oncogenic mutations 
(Benchimol et al., 1989).  In this model, tissue architecture 
and cellular differentiation in heterogeneous cell populations 
is  considered to  be  critically dependent on the  accurate 
spatiotemporal display of a number of specific cell adhesion 
and factor receptor molecules on the cell surface (Edelman, 
1984,  1986; Hatta et al., 1987; Fujimori et al., 1990).  The 
effect of the ectopic introduction of CEA on the cell surface 
is  envisioned  as  being  potentially  disruptive  of normal 
cell-cell interactions which depend on these molecules. 
As a test of this "instrumental" tissue architecture model, 
we have examined the effect of ectopic production of CEA 
in a  well characterized differentiating system, the rat L6 
myoblast. These cells, after reaching confluence in culture, 
undergo cellular alignment followed by fusion and the for- 
mation of  multinucleated myotubes (Yaffe, 1968; Richler and 
Yaffe, 1970; for review see Wakelam, 1985). After prolifera- 
tion to near confluence, the cells withdraw from the cell cy- 
cle before differentiation (Okazaki and Holtzer, 1966), a pro- 
cess which may be inhibited by growth factors (Linkhart et 
al., 1980; Lathrop et al., 1985; Florini et al., 1986), or on- 
cogene activation (Olson et al.,  1987; Payne et al.,  1987; 
Gossett et al., 1988; Rahm et al., 1989). The process of cell 
cycle withdrawal is associated with an upregulation of helix- 
loop-helix transcriptional regulator proteins such as MyoD 
and myogenin (Wright et al., 1989), which have been shown 
recently to interact with the tumor suppressor retinoblas- 
toma protein, pRB, a cell cycle regulator (Gu et al., 1993). 
Normal differentiation and fusion are associated with mod- 
ifications of cell surface glycoproteins (Holland et al., 1984) 
and are inhibited by glycoprotein processing inhibitors (Gilfix 
and Sanwal,  1980; Holland and Herscovics, 1986; Spearman 
et al.,  1987)  and lectins (Den et al.,  1975;  Parfett et al., 
1983). Other necessary modifications include alterations in 
the expression of intercellular adhesion molecules, such as 
a shift in the isoform of the neural cell adhesion molecule 
(Dickson et al., 1990), and changes in the level of cadherins 
(Knudsen et al.,  1990;  Pouliot et al.,  1990).  Thus, the L6 
myoblast represents a well studied model system which de- 
pends  on  multiple  signals,  including  factors,  membrane 
bound receptors and adhesion molecules, for its differentia- 
tion program. 
We have isolated stable CEA cDNA transfectant clones of 
L6 myoblasts and have measured their ability to fuse and 
differentiate. In agreement with the above model, indepen- 
dently  selected  transfectants  producing  relatively  low 
amounts of CEA are unable to differentiate and fuse whereas 
nonproducers, control CEA anti-sense transfectants, myo- 
blasts transfected with an adhesion-defective NH2-terminal 
deletion mutant of CEA (CEAAN), and CEA transfectants 
treated with adhesion-blocking peptides,  differentiate and 
fuse normally. 
Materials and Methods 
Cell Culture and Differentiation 
The rat L6 myoblast cell line was the kind gift of Dr. P. C. Holland of the 
Montreal  Neurological Institute. All experiments were performed using 
cells cultured for fewer than six passages after receipt. Cells were grown 
in monolayer culture in plastic tissue culture flasks or petri dishes contain- 
ing D-MEM supplemented with 10% horse serum (HS) at 37°C in a hu- 
midified atmosphere of 5 % CO2 and 95 % air.  The medium was changed 
every 2-3 d. 
To  promote  fusion and  differentiation, cultures  were  seeded at  104 
cells/cm  2 in 100- or 150-ram  tissue culture plastic petri dishes and grown 
in D-MEM +  10% HS without changing the medium for 5 d, after which 
the medium was replaced with D-MEM  +  2% HS and the cells cultured 
for an additional 5 d. For fusion index determination, ceils were fixed with 
2.5 % glutaraldehyde and stained with haematoxylin and eosin. The fusion 
index was calculated as the number of nuclei within cells containing three 
or more nuclei divided by the total number of nuclei counted. A minimum 
of 500 nuclei in four randomly selected areas was counted for each determi- 
nation. 
Isolation of Transfectants 
30/~g of full length CEA eDNA (Beauchemin et al., 1987) in the sense or 
antisense orientation in the expression vector, p91023B  (courtesy of R. 
Kaufman,  Genetics  Institute,  Boston,  MA)  or  30  #g  of  CEAAN  in 
pDCKdhfr (a gift from S. Oikawa,  Suntory Limited, Osaka, Japan) and 3 
/~g of pSV2neo were cotransfected by electroporation with three pulses of 
350  mV  from 500  #F  (Bio-Rad  Gene  Pulser)  into  10  s  L6  myoblasts. 
CEAAN has a deletion between the Pvu II and Ace I restriction sites in its 
eDNA, resulting in the removal of amino acids 32-106 in the 108-amino 
acid N domain of CEA, and the introduction of an arginine residue between 
tyrosine residues at positions 31 and 107 (or positions 65 and 141, including 
the leader [Beauchemin et al., 1987])- (Oikawa et al., 1991). After incuba- 
tion for 10 min on ice, cells were grown for 48 h in regular growth medium 
after which positive clones were selected by the addition of 400 gg/ml of 
the cytotoxic drug Geneticin G-418 (Sigma Chem. Co., St. Louis, MO). 
To prevent the depletion of myoblasts with high fusion potential, cells were 
not permitted to achieve confluence or differentiate during transfection and 
selection. Clones were picked by micromanipniation under direct micro- 
scopic vision and were checked for their levels of CEA production using 
whole cell sonieates and a CEA double monoclonal antibody clinical kit 
(Abbott CEA-EIA Monoclonal; Abbott Laboratories, North Chicago, IL). 
This assay is highly specific and could not detect the truncated product of 
the CEAAN eDNA. The latter was therefore analyzed using immunoblot- 
ting and immunofluorescence with anti-CEA polyclonal antibody. Verifica- 
tion of cell surface expression of CEA or CEAAN was performed by im- 
munofluorescence with mono- and polyclonal antibodies followed by both 
microscopic examination and analysis with a fluorocytometer (FACScan, 
Becton Dickinson, Immunocytometry Sys., Mountain View,  CA) as de- 
scribed previously (Zhou et al.,  1993). 
Immunoblot Analysis 
Cells from monolayer cultures in the late exponential phase of growth were 
removed from culture dishes with PBS containing 15 mM sodium citrate, 
washed twice in cold PBS, and lysed by sonication in PBS at 4°C. The pro- 
tein concentration of the sonicates was determined by the Bio-Rad protein 
assay (Bio-Rad Labs., Richmond, CA). 50 gg of each of the samples was 
boiled in  Laemmli's buffer (Laemmli,  1970)  for 4  min.  Proteins were 
resolved by electropboresis (Laemmli, 1970) on a 7.5% Tris-glycine-SDS- 
polyacrylamide gel under standard conditions. The proteins were trans- 
ferred to a nitrocellulose membrane (Towbin et al., 1979) and the blot was 
probed successively with anti-CEA polyclonal rabbit antibody and alkaline 
phosphatase-conjngated Affipure goat anti-rabbit IgG(H+L) (Jackson Im- 
muno Research Laboratories, Inc., West Grove, PA). The labeled proteins 
were  detected by  reaction  with  5-bromo-4-chloro-3-indolyl-phosphate- 
nitro-blue  tetrarolium  substrate  (Promega  Fisher  Scientific,  Montreal, 
Quebec). 
Cell Proliferative  Potential 
Replicate plates were seeded with 104 cells/era  2 in 100-ram plates and cul- 
tured as above for the induction of differentiation. At intervals cells were 
removed with trypsin, rendered single cell suspensions and various dilu- 
tions plated in 60-ram tissue culture plates, using aipha-MEM (Stanners et 
al.,  1971) plus 10%  FCS as growth medium. After 10 d of incubation at 
37°C, triplicate plates were fixed in 10% formaldehyde in PBS and stained 
with 0.1% methylene blue. Colonies of 25 cells or more were enumerated 
microscopically. The plating efficiency was calculated by dividing the num- 
ber of colonies obtained by the number of nuclei plated (nuclei rather than 
cells to allow for cell fusion). The number of nuclei plated was determined 
from nuclear counts of replicates of the differentiating cultures which were 
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Values were normalized to the plating efficiency on day 2 for each cell line. 
The absolute plating efficiency was between 78-93 % for all experiments. 
Creatine Phosphokinase Determination 
Monolayer cultures of myoblasts  at various  stages of differentiation  were 
harvested by scraping into ice cold PBS, sonicated, centrifuged at 15,000 
rpm for 5 rain and the supernatant kept at -70°C before assay. 25-50 #1 
of supernatant was  analyzed for creatine phosphokinase (CPK)  activity 
using the  creatine kinase N-acetyl  cysteine-activated  ultraviolet system 
(Boehringer Mannheim Corp., Indianapolis, IN; GmbH Diagnostica)  ac- 
cording to the manufacturer's protocol. The protein concentration of soni- 
cates was determined by the protein assay (Bio-Rad Labs.). Results are ex- 
pressed as tzmol/min/mg  protein. 
Northern Analysis 
Total cell RNA was isolated by the guanidium isothiocyanate  procedure of 
Chirgwin et al. (1979). 20 #g of RNA was electrophoresed on 1.1 M formal- 
dehyde, 1.5 % agarose gels and transferred to nitrocellulose filters (Maniatis 
et al.,  1982).  Detection of myogenin and/~-actin bands was accomplished 
with random primer 32p-labeled myogenin cDNA (courtesy  of W. Wright, 
Houston, TX) or chicken B-actin cDNA hybridized at 42°C in 5x  SSPE 
(Ix SSPE is 0.18 M NaCI plus 10 mM NaPO4 [pH 7.7] plus 1 mM EDTA), 
5 x  Denhardt's solution, 50 % formamide,  150 ttg of heat denatured salmon 
testis DNA, 0.5%  SDS, for 18 h. The membrane was then washed in 2x 
SSPE  +  1% SDS at 20°C,  twice in lx  SSPE  +  0.1% SDS at 65°C,  and 
twice in 0.1x SSPE + 0.1% SDS at 65°C. To control for the amount of RNA 
added,  blots  were  stripped  and  reprobed with the  18S  rRNA  specific 
oligomer 5'-ACGGTATCTGATCGTCTTCGAACC-3', end-labeled with 32p 
using T4-kinase (Maniatis et al., 1982). Labeled oligonucleotide  was sepa- 
rated from free 32p with a CJs Sep-Pak  column (Waters Associates,  Mil- 
ford,  MA). Hybridization was performed in 5x  SSPE,  10x  Denhardt's, 
250/~g/ml tRNA, 7% SDS, and 10% dextran sulfate, for 18 h at 37°C. The 
membranes were then washed twice in Ix  SSC  +  0.1% SDS at 20°C. 
Production of  Bacterial Fusion Peptides 
Constructs consisting of the 108-amino acid N domain and the 178-amino 
acid  A1B1, A2B2,  and  A3B3  domains  of CEA  fused  to  the  E.  coil 
CTP:CMP-3-deoxy-rnanno-octulosonate  eytidyltransferase  (CKS)  gene 
were expressed in E. coli and the products purified according to the protocol 
of Hass et al. (1991) as described previously (Zhou et al., 1993). After dial- 
ysis  against D-MEM,  the fusion peptides were added to differentiation 
medium to a final concentration of 1 mg/ml and incubation continued as 
indicated.  In some cases medium was changed to medium containing fresh 
peptide  after 2 days' incubation. 
Results 
Effect of CEA Production on l~sion 
L6 myoblasts were cotransfected with pSV2neo and with 
CEA, antisense CEA, or CEAAN cDNAs, and stable trans- 
fectant clones were selected. CEAAN contains a deletion of 
the  last  75  amino  acids  of  the  108-amino  acid  NH2- 
terminal domain, retaining the processed leader sequence, 
and is completely defective in adhesion function when ex- 
pressed on the surface of CHO cell transfectants (Oikawa et 
al.,  1991;  Zhou  et  al.,  1993).  Transfectant clones  were 
picked and  cell  surface expression of CEA  was  assessed 
using polyclonal and monoclonal antibodies. CEA produc- 
tion in positive clones was between 40 and 800 ng CEA/mg 
protein of total cell lysate using a calibrated double mono- 
clonal antibody assay. This same assay, however, did not de- 
tect the product expressed by the mutant CEAAN transfec- 
tants. A Western blot of electrophoretically separated total 
Figure L  Western blot and cytofluorimetric 
profiles of L6 transfectants. (Left) Samples 
of total cell lysate were electrophoresed on 
a 7.5% polacrylamide gel and transferred to 
nitrocellulose  paper.  The  blot  was  in- 
cubated  with  polyclonal  rabbit  anti-CEA 
antibody, and then with alkaline phospha- 
tase-conjugated goat anti-rabbit Ig and de- 
veloped  with  NI~-BCIP  as  described  in 
Materials and Methods. The major bands at 
~200  kD  in  molecular  weight  represent 
fully glycosylated CEA, whereas the minor 
bands at ~120 Kd in molecular weight are 
due  to  partially  glycosylated  CEA,  as 
shown for other transfectants (unpublished 
data). The very faint band at the top of the 
gel  in  the  L6  lane  was  not  reproducible. 
(Right)  Cytofluorimetric profiles of paren- 
tal L6 ceils together with the L6 CEA trans- 
fectant L6-17,  L6-17  after  18  and 41  pas- 
sages  without  G418  selection,  the  L6 
CEAAN transfectant L6-16 (Table I) and a 
high-producer  population, L6(CEAAN)-H, 
sorted from the higher producers in the 1_,6- 
16  CEAAN  transfectant  population  by 
FACS; whole cells were stained using poly- 
clonal anti-CEA rabbit antibody and ana- 
lyzed  as  described  in  Materials  and 
Methods.  Fusion could  not be induced in 
the L6-17 transfectant after 18 passages but 
was restored after 41  passages. 
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with polyclonal CEA antiserum is shown in Fig. 1. No CEA 
bands could be detected in lysates of the parental L6 myo- 
blasts. Two CEA transfectant clones, which produced 104 
and 837 ng CEA/mg protein, showed prominent bands of the 
expected molecular weight for fully glycosylated  CEA. Most 
of the data presented below was obtained using the clone, 
L6-17, producing 104 ng CEA/mg protein, although similar 
results were obtained with all transfectant clones producing 
more than  100  ng CEA/mg protein  (Table  I).  The three 
CEAAN transfectant clones displayed intermediate levels of 
production of a protein with a predictably lower molecular 
weight (Fig.  1),  which was  shown by immunofluorescent 
staining with polyclonal anti-CEA antibody to appear on the 
surface of the cells (data not shown). Quantitative measures 
of the cell surface levels of CEA and CEAAN were pro- 
vided by cytofluorimetric profiles of various  transfectant 
clones stained with anti-CEA antibody, including a CEA~N 
high-producer  population,  L6(CEAAN)-H,  obtained  by 
FACS sorting of the second peak of the CEAAN transfectant 
(Fig.  1). 
After reaching confluence and after the serum concentra- 
tion of  the growth medium is reduced from 10 to 2% 5 d after 
seeding the cultures, L6 myoblasts align and start to fuse into 
myotubes of multinucleated cells. A dramatic difference was 
observed in the ability of the L6 CEA transfectants to fuse; 
after 9 d in culture, these transfectants showed single cells 
which failed completely to align and fuse, whereas the pa- 
rental cells and CEA~N transfectants showed extensive fu- 
sion  (Fig.  2).  The  quantitation  of  this  phenomenon  is 
presented in Fig.  3.  Seventy-nine percent of wild-type L6 
myoblasts fused into myotubes by 9 d after plating; control 
CEAAN transfectants demonstrated a fusion index similar to 
that of the parental cells (82%). In contrast, CEA transfec- 
tants showed no fusion whatsoever (Fig. 3). A complete ab- 
sence of fusion was also observed for two other CEA trans- 
fectant clones producing more than 100 ng CEA/mg protein 
whereas a reduced fusion index of 21% was seen for a clone 
producing 40 ng CEA/mg protein (Table I); all these clones 
were obtained from independent transfections. Ten indepen- 
dent control clones, including CEAAN, the CEAAN high- 
producer, CEA antisense, and pSV2neo (only) transfectants, 
fused normally (Table I and data not shown). The results are 
thus unlikely to be due to the selection of spontaneous L6 
variants that lack fusion ability (Kaufman and Parks, 1977). 
To rule out this possibility entirely, the nonfusing CEA trans- 
fectant L6-17 was cultured in the absence of G418 selection 
for 43 passages, in order to lose production of CEA; at pas- 
sage 18, cell surface production of CEA had fallen markedly 
(Fig. 1), yet fusion ability was essentially normal; at passage 
37, when CEA production was only 0.5 ng/mg protein, fu- 
sion ability returned fully to previous nontransfected levels 
(79%) (Fig. 2 and Table I); L6-17 maintained under selection 
for the same number of  passages, on the other hand, was still 
completely unable to fuse (data not shown). The fact that this 
reversion to full differentiation capacity required loss of vir- 
tually all CEA production also shows that very little CEA is 
required  to block  fusion.  Lastly, growth rate differences 
were not involved since there was no significant difference 
in the rate of  proliferation of the transfectants compared with 
the  parental  myoblasts;  in  addition,  the  cell  volume  of 
Table L Differentiation Parameters for L6 Transfectants 
Transfected  CEA production Fusion CPK¢ (fold 
Clone  construct*  (rig~rag)  index  increase) 
L6  -  0  0.81  11 
L6-N  pSV2Neo  0  0.84  15 
L6-27  CEA-antisense  0  0.78  18 
L6-23  CEA-antisense  0  0.63  nd** 
L6-16  CEA~N  >100¶  0.82  19 
L6-16-H  CEAAN  >300  0.50  ncl 
L6-18  CEA  0  0.83  13 
L6-73  CEA  40  0.21  nd 
L6-17  CEA  104  0  I 
L6-71  CEA  212  0  nd 
L6-82  CEA  837  0  1 
L6-17-37(-)§  CEA  0.5  0.79  10 
L6-17-43(-)§  CEA  0.2  0.76  10 
L6-17+NII  CEA  104  0.47  nd 
L6-17+A3B311  CEA  104  0.58  nd 
L6-17+N+A3B311  CEA  104  0.51  nd 
L6-17 +A1Blll  CEA  104  0.04  nd 
L6-17 +A2B211  CEA  104  0.01  nd 
* All cell lines were cotransfected with pSV2Ne and expression constructs 
containing the indicated eDNA. 
The fold increase in CPK activity was calculated relative to the activity  of 
nonfusing L6 cells. 
§ The L6-17 CEA transfectant maintained in culture without selection with 
G-41S for 37 and 43 passages, resulting in a reduction in the original level (104 
ng/mg) of CEA production. 
II Fusion peptides CKS-N, CKS-AIB1, CKS-A2B2, and CKS-A3B3 made in 
bacteria and containing the N, AIBI, A2B2, or A3B3 domains of CEA were 
added  to  1  mg/ml to  transfectant cultures  in  differentation  medium and 
incubated for 4 d. 
¶ Estimated from data shown in Fig.  1. 
** Not done. 
proliferating CEA transfectant and parental myoblasts was 
identical (data not shown). 
CEA-mediated adhesion requires a double-reciprocal in- 
teraction between the V-like N domains and the membrane- 
proximal C2-1ike A3B3 internal domains of antiparallel mol- 
ecules on apposing  cell  surfaces;  thus treatment with  N 
domain or A3B3 domain peptides made in bacteria can in- 
hibit  intercellular  adhesion  completely,  while  AIB1 and 
A2B2 peptides are much less effective (Zhou et al., 1993). 
Treatment of nonfusing L6 CEA transfectants in differentia- 
tion medium with either or both of the N and A3B3 peptides 
was found to restore differentiation and fusion to 50-60% 
with approximately the same kinetics as the parental L6 cells 
when exposed to differentiation medium, whereas the AIB1 
and A2B2 peptides were without effect (Table I and Fig. 2). 
The concentration of the N and A3B3 peptides required to 
restore  fusion  capacity  to  the  L6  CEA  transfectants  (1 
mg/ml) was similar to that required to block aggregation of 
CHO CEA transfectants in suspension (2 mg/ml) (Zhou et 
al., 1993). These results strongly implicate the necessity for 
adhesive interactions between CEA molecules on apposed 
cells to block L6 differentiation and fusion. 
Effect of CEA on Molecular Measures 
of Differentiation 
Nonfusing myoblasts which still demonstrate all the molecu- 
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sponding  protein  domains  for  CEA  and 
CEAAN. (B) Morphology of  parental L6 myo- 
blasts, an L6 CEA transfectant clone, the same 
L6 CEA transfectant clone after 37 passages to 
lose CEA production, the L6 CEA transfectant 
clone, treated with 1 mg/ml CEA A3B3 pep- 
tide for 4 d and the L6 CEAAN transfectant 
clone,  under  culture  conditions  promoting 
differentiation (see  Materials  and  Methods). 
Cells were fixed in glutaraldehyde and stained 
with hematoxylin. (Magnification x200). 
lar changes required for differentiation have been described 
(Pinset and Whalen,  1984; Olson et al.,  1987). To explore 
the possibility that the nonfusing phenotype in CEA transfec- 
tants was due to an uncoupling of fusion from differentiation, 
we examined the production of CPK, a muscle specific en- 
zyme which is upregulated in differentiated myoblasts (O1- 
son et al., 1983), myogenin, a helix-loop-helix  key transcrip- 
tional regulator protein whose production is induced early 
in  L6 myoblast differentiation (Wright et al.,  1989),  and 
/3-actin  which  is  downregulated  in  developing  myotubes 
(Endo and Nadal-Ginard,  1987). 
Creatine Phosphokinase 
CPK levels (Fig. 4, Table I) rose 10-20-fold after 7 d in cul- 
ture in both L6 parental cells and in control CEAAN trans- 
fectants. In contrast, CEA transfectants showed no increase 
in CPK activity and remained at basal  levels throughout. 
CEA antisense, pSV2neo, and L6A7 transfectants which had 
lost CEA expression due to prolonged passage without se- 
lection showed increases in CPK levels comparable to L6 
parental cells (Table I).  Thus, ectopic production of CEA 
completely blocks the normal induction of CPK with differ- 
entiation. 
Myogenin 
Northern blot analysis  of total  cell RNA  with  myogenin 
cDNA as a probe (Fig. 5) demonstrated a dramatic rise in 
myogenin mRNA in the parental L6 myoblasts and control 
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Figure 3. Fusion index of L6 parental myoblasts and transfectants 
with time in culture. Parental L6 myoblasts (I) and CEA (e), or 
CEAAN (A), transfcctants were plated at 104 cells/cm 2 and grown 
under fusion-promoting conditions. At the indicated intervals after 
plating,  the cells were fixed, stained  with hematoxylin,  and the 
mean fusion index (nuclei in cells with >3 nuclei/total nuclei) was 
determined. Values shown arc the mean of at least 3 determinations 
of >500 nuclei each. Error bars represent the standard error of the 
me.an. 
transfectants, starting 5 d after plating, i.e., before the large 
increase in the fusion index (Fig. 3). In contrast, the CEA- 
producing transfectant clones showed absolutely no increase 
in myogenin mRNA (Fig. 5). Since the induction of this cen- 
tral transcriptional regulator represents a key early event in 
the myoblast differentiation program,  this  result indicates 
that CEA intercepts the process at a relatively early stage. 
Actm 
The same Northern blot used for the myogenin analysis was 
probed with/3-actin eDNA.  The predicted dowm'egulation 
of actin mRNA in parental L6 myoblasts and control trans- 
fectants during fusion and differentiation was observed (Fig. 
5).  In contrast,  the CEA L6 transfectant clone showed no 
reduction in the/~-actin mRNA. The same blot rehybridized 
with a 24-mer probe specific for 18S RNA is shown to dem- 
onstrate that equal amounts of RNA were analyzed in each 
lane. 
These results demonstrate that all three molecular aspects 
of myoblast differentiation, even relatively early events, were 
blocked by the production of CEA. 
Effect of CEA on Cellular Proliferative Potential 
The relative plating efficiency for colony formation by L6 
myoblasts and various transfectants at different times during 
the differentiation cycle was measured (Fig. 6). The plating 
efficiency of the parental myoblasts and CEAAN transfec- 
tants declined markedly with time in culture and with ki- 
netics which indicate that irreversible withdrawal from the 
cell cycle, as measured by this assay, precedes fusion and 
differentiation. The residual proliferative capacity of •  20 % 
at day 9 reflects the proportion of nonfused cells. Compara- 
ble  declines  in  plating  efficiency  were  seen  in  control 
pSV2neo transfectants (data not shown). In contrast, CEA 
transfectant  clones  retained  their  proliferative  capacity, 
maintaining a relative plating efficiency of ~75 % until day 
9. Thus the expression of CEA abrogated terminal differenti- 
ation and allowed cells to maintain their division potential. 
Discussion 
The overexpression of CEA family members in many types 
of human tumors and their function in vitro as intercellular 
adhesion molecules raise the possibility that this correlation 
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Figure 4. CPK production in L6 parental myoblasts and transfec- 
tants  with time in culture.  Parental  L6 myoblasts (u)  and CEA 
(e), or CEAAN (A), transfectants were plated and grown under 
conditions to promote fusion.  Lysates were obtained  at the indi- 
cated intervals and assayed for CPK production.  Values shown are 
the means of  three samples and are adjusted to the total protein con- 
tent of each sample.  Error bars represent  standard errors of the 
mean and points with no apparent error bars have errors smaller 
than the symbols. 
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Figure 5.  Myogenin and actin mRNA levels in L6 parental  myo- 
blasts and transfectants with time in culture. L6 myoblasts (L6), L6 
transfected with PSV2neo alone  (L6neo), or L6 transfected with 
CEA (L6 CEA+), were grown in culture under conditions to pro- 
mote fusion. At the indicated intervals, cells were harvested,  and 
total cell RNA was prepared.  Aliquots of the RNA were resolved 
by electrophoresis,  transferred to a nitrocellulose membrane, and 
hybridized successively with probes for myogenin and ~-actin, un- 
der high stringency conditions. The same blot as rehybridized with 
a labeled 18S ribosomal RNA-specific oligomer to give an indepen- 
dent measure of the amount of RNA electrophoresed in each lane. 
The major band just below the 18s marker represents the myogenin 
transcript (Wright et al., 1989); the significance of the other bands 
is not known. 
has a  mechanistic basis.  One such model suggested previ- 
ously proposes a role for adhesion molecules in maintaining 
normal tissue architecture, with inappropriate expression in 
tumors leading to distortion in architecture and the disrup- 
tion of cellular differentiation (Benchimol et ai.,  1989).  In 
this model, cellular differentiation in multicomponent cellu- 
lar systems is considered to depend on the accurate interplay 
of a number of recognition molecules on apposing cell sur- 
faces; the introduction of a previously absent adhesion mole- 
cule, or a large change in the level of a previously existing 
one, is proposed to distort the fidelity of the process. To test 
this model, we have studied the effects of ectopic expression 
of CEA  on differentiation in  a  model  system,  the  rat L6 
myoblast, and have found that expression of relatively low 
amounts of CEA on the surface of these cells results in a 
complete block in their ability to fuse and differentiate. 
The possibility that  CEA  had  uncoupled  differentiation 
from fusion, as can occur, for example, when divalent cations 
are  removed from the  culture  medium (Endo  and  Nadal- 
Ginard, 1987), is not the case because myoblast CEA trans- 
fectants did  not  show any of the molecular changes char- 
acteristic  of differentiation,  including  the  upregulation  of 
creatine phosphokinase or myogenin mRNA levels or the 
downregulation of/3-actin mRNA levels. Myogenin is a tran- 
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Figure 6. Plating efficiency of L6 parental myoblasts and transfec- 
tants  with time in culture.  Parental  L6 myoblasts (m) and CEA 
(e), or CEAAN  (A), transfectants  were plated and grown under 
conditions to promote fusion. At the indicated intervals the mean 
plating efficiency (colonies/nucleus plated) was determined. Values 
shown are the mean of at least three determinations and are normal- 
ized to the plating efficiency at day 2. Error bars represent the stan- 
dard error of  the mean. The fusion index curve for L6 parental myo- 
blasts (---) is shown for comparison. 
scriptional regulator involved early in myogenic differentia- 
tion and believed to be pivotal in subsequent steps in the pro- 
gram (Wright et al.,  1989) so that the complete inhibition of 
its normally dramatic upregulation indicates the interception 
by CEA of the differentiation program at a very early stage. 
Furthermore, CEA transfectants failed to withdraw from the 
cell cycle and maintained a high division potential. The ac- 
tivity of helix-loop-helix proteins such as MyoD and myoge- 
nin has been shown to depend on interaction with the active 
form of the cell growth cycle regulator, retinoblastoma pro- 
tein (pRB), such that inactivation of pRB by phosphorylation 
or binding of viral proteins such as large T antigen can block 
myogenesis (Gu et al.,  1993).  It seems unlikely, however, 
that the effect of CEA on myogenesis is due to inactivation 
of pRB,  since this would not itself explain the absence of 
myogenin mRNA. We are nonetheless currently investigat- 
ing the status of pRB in the L6 CEA transfectants. 
The results cannot be ascribed to the selection of nonfus- 
ing variants of L6. Thus, multiple independent CEA trans- 
fectant clones  all  failed to differentiate,  whereas  multiple 
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normally; in addition, full fusion capacity returned to a pre- 
viously  nonfusing  CEA  transfectant  that  had  lost  CEA 
production by extended culture without selection. Finally, 
fusion was not affected by the expression of very high levels 
of an adhesion-defective truncated CEA molecule with a de- 
letion in the N domain and prompt fusion of L6 CEA trans- 
fectants was obtained after addition of CEA N domain or 
A3B3 domain peptides (Fig. 2), which inhibit CEA medi- 
ated intercellular adhesion. The latter, along with the failure 
of A1B1 and A2B2 domain peptides, which have much less 
effect on adhesion, to restore fusion, constitutes strong evi- 
dence that the proposed  double reciprocal bonding of Ig 
V-like N to Ig C2-1ike A3B3 domains between antiparallel 
CEA molecules on apposed L6 cell surfaces (Zhou et al., 
1993)  is required for the antidifferentiation effect. Direct 
measurement of the adhesive effects  of CEA and the an- 
tiadhesive effects ofpeptides in the L6 transfectants could not 
be achieved due to the presence of  many other adhesion mol- 
ecules in the parental L6 cells which gave a strong "back- 
ground" intercellular adhesion. The rapid resumption of the 
differentiation program in L6 CEA transfectants maintained 
in differentiation medium when treated with N or A3B3 do- 
main peptides (fusion begins within 1 day-unpublished re- 
suits) indicates that these cells are primed for fusion and that 
other adhesion molecules required for fusion are  not re- 
pressed. These results also show that the L6 CEA transfec- 
tants in confluent culture in differentiation medium are held 
in a state which can rapidly access either fusion or division. 
Thus the entire program for differentiation, which L6 my- 
oblasts normally undergo as a result of cell surface interac- 
tions involving ligand-receptors and other adhesion mole- 
cules such as cadherins and N-CAM, is abrogated by the 
presence on the surface of a new adhesion molecule, CEA. 
This effect is specific for CEA, since overexpression by trans- 
fection of myoblasts with cDNA coding for the GPI-linked 
form of another adhesion molecule of the immunoglobulin 
supergene  family, N-CAM,  which is  itself positively in- 
volved in fusion, actually stimulated fusion by accelerating 
the process (Dickson et al., 1990). As mentioned above, the 
intercellular adhesive function of CEA is necessary for the 
effect. Our working hypothesis is that CEA interferes with 
the function of other adhesion molecules or signal transduc- 
tion processes required for normal differentiation. 
The interference envisioned could be extracellular ("ecto") 
by direct interaction of CEA with other cell surface mole- 
cules  or  intracellular  Cendo')  by  interception  of normal 
transduced molecular event sequences by a CEA-induced se- 
quence. A special type of endo effect could arise from the 
fact that CEA is a heavily glycosylated  protein; thus the pos- 
sibility exists that its overexpression could saturate protein 
glycosylation pathways, thereby preventing the full matura- 
tion of cell surface glycoproteins required for the normal fu- 
sion and differentiation of L6 myoblasts, including other 
adhesion molecules. This explanation seems unlikely since 
the high-producer CEAAN transfectants, which expressed a 
slightly smaller but heavily glycosylated CEA analog on 
their cell surface at a model level of 100-fold more than the 
minimum amount of CEA required to block fusion (Fig. 1), 
had a normal fusing phenotype. 
Considering  ecto  effects,  CEA  is  a  highly  negatively 
charged molecule due to the terminal sialic acid residues on 
its 28 N-linked sugar side chains. It could thus introduce a 
negative charge in the intermembrane space which could in- 
terfere with the adhesive function of other adhesion mole- 
cules. This hypothesis has been suggested for the antiadhe- 
sive effects of N-CAM seen in some situations, in this case 
because of its highly negatively charged specialized poly- 
sialic acid structure attached to a domain close to the cell 
membrane (Rutishauser et al.,  1988).  Again, if this is the 
mechanism of the CEA effect, it must also require CEA in- 
termolecular adhesion since very high levels of the nonadhe- 
sive  CEAAN  molecule,  with  almost  as  many  charged 
residues as CEA itself, on the cell surface allow L6 differen- 
tiation.  Adhesion by CEA  molecules  could be  required, 
however, since it would produce high local concentrations of 
charge at apposed regions of the membranes,  so that this 
mechanism still seems plausible. Experiments are in prog- 
ress to study directly a potential role of the terminal sialic 
acid residues in CEA. 
Considering endo effects, the failure of the CEA transfec- 
tants to withdraw irreversibly from the cell cycle suggests 
that CEA production inhibits a terminal differentiation path- 
way which normally is induced after the cells reach conflu- 
ence and experience a deficiency of mitogenic stimuli. This 
could be due to the stimulation by CEA of a competing path- 
way, thus representing an endo effect ofCEA; BGP, a closely 
related family member with transmembrane and cytoplas- 
mic domains,  for example,  has been suggested to be as- 
sociated with protein tyrosine kinases in the cell membrane 
(Afar et al., 1992) and recent results have shown an associa- 
tion of CEA itself with src-family kinases (Draber, P., and 
C. P.  Stanners, unpublished results). Alternatively, loss of 
proliferative capacity could  simply be  a  terminal conse- 
quence of cell fusion so that blockage of fusion would natu- 
rally lead to retention of division capacity. This effect of 
CEA again requires an intact NH2-terminal domain, i.e., 
presumably its intercellular adhesion function, given that the 
CEAAN transfectants lost cell division potential normally. 
Additional work will be required to elucidate the nature 
of the signals required for differentiation and loss of division 
potential which the CEA-CEA interactions on the cell sur- 
face distort or perhaps block. The generality of the phenom- 
enon for the ectopic expression of other adhesion molecules 
in other differentiating systems also deserves investigation. 
Regardless of the mechanism involved, the failure to with- 
draw from the cell cycle and differentiate suggests that aber- 
rant expression of CEA, a human tumor marker, could rep- 
resent one step in the progression of a cell towards an overt 
malignant phenotype. 
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